The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUAI.L Regulatory News (UAI)

  • There is currently no data for UAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Development & Trading Update

20 Mar 2020 07:00

RNS Number : 8923G
U and I Group PLC
20 March 2020
 

 

This announcement contains inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

 

 

20 March 2020

 

U and I Group PLC

 

Development & Trading Update

U+I (LSE:UAI), the specialist regeneration developer and investor, today announces an update to its anticipated development and trading gains for FY2020.

Brexit, the related slowdown in decision-making and the only recently resolved political uncertainty in the UK have continued to impact upon timing of some of our projects. In particular this has led to delays in securing planning consents following the election purdah and a further slowdown in transaction timetables. This has recently been dramatically exacerbated by the impact of Covid-19 on the decision-making process, business sentiment and economic activity. The rapidly accelerating impact of the Covid-19 crisis on transactional activity and Central and Local Government policy means that there is currently no reliable way to predict, with certainty, the timing or value of transactions. However, it is now unlikely that sufficient of the projects set out in our guidance at our interim results on 20 November 2019 will contract by 31 March 2020 to enable us to meet the lower end - £35 million - of our gains target for the year. In the normal course of events, we would expect some of the deferred projects to be realised in FY2021 and will provide further detail of these in our full year results.

Based on the projects on which we have certainty, the aggregate amount of our development and trading gains number is currently materially below that £35 million target for the full year. That said, we remain in advanced legal negotiations on several projects within our flexible and substantial development portfolio, including Harwell. If successfully concluded, these could have a material impact on our reported end of year total gains, albeit we expect that amount would still be below the £35 million lower end target. Given the confidential nature of these discussions, the Company is not yet in a position to provide a more detailed review of target gains as it believes this could prejudice its commercial position.

U+I has been actively managing its cost base and in the current climate it will be proactively reducing its operating expenses and all non-essential capital expenditure, with regular discussions to review these key areas and help mitigate risk. It also has the ability to access credit facilities should they be required to manage its liquidity needs, utilising its currently uncharged assets as security.

In addition to RNS releases once transactions close, a post close statement will be issued in early April updating the market on gains, trading and its cost mitigation actions.

Ends

 

 

 

For further information, please contact: 

 

U+I

Nicola Krafft

+44 (0) 20 7828 4777

ir@uandiplc.com

 

Camarco (Financial PR Adviser)

Geoffrey Pelham-Lane / Tom Huddart

+44 (0)20 3757 4985 / 4991

uandi@camarco.co.uk 

 

About U+I

U+I is a specialist regeneration developer and investor.

 

With a >£11.5 billion portfolio of complex, mixed-use, community-focused regeneration projects including a £147.1 million investment portfolio, we are unlocking urban sites bristling with potential in the London City Region (within one hour's commute from Central London), Manchester and Dublin. We exist to create long-term socio-economic benefit for the communities in which we work, delivering sustainable returns to our shareholders.

 

To find out more, visit www.uandiplc.com or follow us @uandiplc  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUKRRRRSUOAUR
Date   Source Headline
2nd Nov 20213:25 pmRNSForm 8.3 - U AND I GROUP PLC
2nd Nov 20213:20 pmRNSForm 8.3 - U and I Group plc
2nd Nov 20212:30 pmRNSForm 8.3 - U and I Group plc
2nd Nov 20212:19 pmRNSForm 8.3 - U and I Group plc
2nd Nov 20211:55 pmGNWDimensional Fund Advisors Ltd. : Form 8.3 - U AND I GROUP PLC - Ordinary Shares
2nd Nov 20211:04 pmPRNForm 8.3 - U and I Group Plc
2nd Nov 202112:00 pmRNSForm 8.5 (EPT/RI) - U and I Group Plc
2nd Nov 202111:23 amPRNForm 8.3 - U & I Group plc
2nd Nov 202111:21 amRNSForm 8.5 (EPT/RI) - U and I Group plc
2nd Nov 202110:40 amRNSForm 8.3 - U AND I Group Plc
2nd Nov 20219:52 amRNSForm 8.5 (EPT/RI)
2nd Nov 20219:45 amRNSForm 8.3 - U and I Group Plc
1st Nov 202111:53 amRNSRule 2.9 Announcement
1st Nov 20217:00 amRNSRecommended cash offer for U and I Group PLC
1st Oct 202112:02 pmRNSDirector/PDMR Shareholding
9th Sep 20213:56 pmRNSResult of AGM
8th Sep 20217:00 amRNSMorden Wharf planning decision
26th Jul 20218:00 amRNSDirector/PDMR Shareholding
20th Jul 202111:15 amRNSHolding(s) in Company
8th Jul 20217:30 amRNSHolding(s) in Company
1st Jul 202111:44 amRNSDirector/PDMR Shareholding
30th Jun 20212:57 pmRNSDirector/PDMR Shareholding
29th Jun 20214:49 pmRNSDirector/PDMR Shareholding
23rd Jun 20214:20 pmRNS8 Albert Embankment planning decision
18th Jun 20217:01 amRNSAnnual Financial Report and Notice of AGM
9th Jun 20213:27 pmRNSDirector/PDMR Shareholding
2nd Jun 20217:00 amRNSDirector/PDMR Shareholding
26th May 20217:07 amRNSResults for the year ended 31 March 2021
26th May 20217:00 amRNSBoard Changes
11th May 20217:00 amRNSAppointment of CFO
14th Apr 20214:35 pmRNSPrice Monitoring Extension
31st Mar 20214:51 pmRNSDirector/PDMR Shareholding
31st Mar 20214:20 pmRNSDirector/PDMR Shareholding
10th Feb 20215:06 pmRNSDirector/PDMR Shareholding
27th Jan 20217:30 amRNSDirector/PDMR Shareholding
26th Jan 202110:45 amRNSDirector/PDMR Shareholding
25th Jan 20212:54 pmRNSHolding(s) in Company
25th Jan 20212:38 pmRNSDirector/PDMR Shareholding
21st Jan 20214:29 pmRNSDirector/PDMR Shareholding
19th Jan 20217:01 amRNSInterim Results
19th Jan 20217:00 amRNSDirectorate Changes
5th Jan 202111:06 amRNSDirector/PDMR Shareholding
4th Jan 202110:23 amRNSBlock listing Interim Review
27th Nov 20204:40 pmRNSSecond Price Monitoring Extn
27th Nov 20204:36 pmRNSPrice Monitoring Extension
16th Nov 20207:00 amRNSNotice of Interim Results
30th Sep 20203:02 pmRNSDirector/PDMR Shareholding
24th Sep 20207:00 amRNSPositive planning decision in Tunbridge Wells
18th Sep 20207:00 amRNSNew joint venture partnership
10th Sep 20201:43 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.